Literature DB >> 15688290

The role of toll-like receptors in herpes simplex infection in neonates.

Evelyn A Kurt-Jones1, John Belko, Catherine Yu, Peter E Newburger, Jennifer Wang, Melvin Chan, David M Knipe, Robert W Finberg.   

Abstract

Toll-like receptors (TLRs)--and their associated signal-transducing proteins--on the surface of cells have been demonstrated to account for most, if not all, of the events associated with bacterial sepsis. Using human cells expressing different TLRs, we demonstrated that the interaction between TLR2 and herpes simplex virus (HSV)-1-2 leads to the production of cytokines. Using peripheral-blood mononuclear cells, we tested the ability of cells from people of different age groups to make cytokines in response to HSV. An examination of the host responses of neonates to HSV indicates that, rather than producing less interleukin-6 and interleukin-8 in response to HSV than adults do, neonates produce more of these cytokines than adults do. This may explain the sepsis syndrome that is seen with HSV (and other virus infections) in neonates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15688290     DOI: 10.1086/427339

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses.

Authors:  Gargi Dasgupta; Aziz Alami Chentoufi; Sylvaine You; Payam Falatoonzadeh; Lourie Ann A Urbano; Ayesha Akhtarmalik; Kimberly Nguyen; Lilit Ablabutyan; Anthony B Nesburn; Lbachir BenMohamed
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

2.  Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells.

Authors:  Ayuko Sato; Melissa M Linehan; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

Review 3.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 4.  Toll-like receptors regulation of viral infection and disease.

Authors:  Joseph M Thompson; Akiko Iwasaki
Journal:  Adv Drug Deliv Rev       Date:  2007-12-28       Impact factor: 15.470

5.  Herpesvirus tegument protein activates NF-kappaB signaling through the TRAF6 adaptor protein.

Authors:  Xueqiao Liu; Katherine Fitzgerald; Evelyn Kurt-Jones; Robert Finberg; David M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-05       Impact factor: 11.205

6.  The case for immunomodulatory approaches in treating HSV encephalitis.

Authors:  Chandran Ramakrishna; Harry Openshaw; Edouard M Cantin
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

Review 7.  Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.

Authors:  Evelyn A Kurt-Jones; Megan H Orzalli; David M Knipe
Journal:  Adv Anat Embryol Cell Biol       Date:  2017       Impact factor: 1.231

8.  Prognostic factors for survival of herpes simplex virus-associated hemophagocytic lymphohistiocytosis.

Authors:  Motoshi Sonoda; Masataka Ishimura; Katsuhide Eguchi; Akira Shiraishi; Shunsuke Kanno; Noriyuki Kaku; Hirosuke Inoue; Yoshitomo Motomura; Masayuki Ochiai; Yasunari Sakai; Manabu Nakayama; Osamu Ohara; Shouichi Ohga
Journal:  Int J Hematol       Date:  2019-09-23       Impact factor: 2.490

9.  Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2.

Authors:  Scott J Schachtele; Shuxian Hu; Morgan R Little; James R Lokensgard
Journal:  J Neuroinflammation       Date:  2010-06-28       Impact factor: 8.322

10.  A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo.

Authors:  Craig W Day; Ralph Baric; Sui Xiong Cai; Matt Frieman; Yohichi Kumaki; John D Morrey; Donald F Smee; Dale L Barnard
Journal:  Virology       Date:  2009-10-22       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.